ABCC1 and chronic myelogenous leukemia, BCR-ABL1 positive: In addition, such overexpression showed to have a remarkable decrease in the expression of some ABC transporters (ABCG2, ABCC1 and ABCB1), and finally reversing the imatinib resistance in CML cells.